Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. - Related Studies

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

This study has been completed.

Study NCT00034125. Last updated on July 18, 2006. Information provided by Eli Lilly and Company

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Neoplasms

2	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Skin Diseases

3	Interventions listed in this trial
		LY353381
		tamoxifen

4	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Bone Density Conservation Agents
		Estrogen Antagonists
		Estrogen Receptor Modulators
		Hormone Antagonists
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Selective Estrogen Receptor Modulators
		Therapeutic Uses

5	Sponsors listed in this trial
		Eli Lilly and Company